Charles Baker-Glenn

Charles Baker-Glenn

Charles River Laboratories International, Inc - Wilmington / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5656781
person_outline Charles Baker-Glenn's MOST POPULAR ARTICLES
1-) Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAA Estrada, X Liu, C Baker-Glenn, A Beresford, DJ Burdick, M Chambers, ...Journal of medicinal chemistry 55 (22), 9416-9433, 20121622012
2-) Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAA Estrada, BK Chan, C Baker-Glenn, A Beresford, DJ Burdick, ...Journal of medicinal chemistry 57 (3), 921-936, 20141392014
3-) Total Synthesis of (−)‐Ulapualide A: The Danger of Overdependence on NMR Spectroscopy in Assignment of StereochemistryG Pattenden, NJ Ashweek, CAG Baker‐Glenn, GM Walker, JGK YeeAngewandte Chemie International Edition 46 (23), 4359-4363, 2007582007
4-) Discovery of a highly selective, brain-penetrant aminopyrazole LRRK2 inhibitorBK Chan, AA Estrada, H Chen, J Atherall, C Baker-Glenn, A Beresford, ...ACS medicinal chemistry letters 4 (1), 85-90, 2013532013
5-) A catalytic asymmetric bioorganic route to enantioenriched tetrahydro-and dihydropyranonesC Baker-Glenn, N Hodnett, M Reiter, S Ropp, R Ancliff, V GouverneurJournal of the American Chemical Society 127 (5), 1481-1486, 2005472005